Phase transfer catalyzed glycosidation of an indolocarbazole

Details for Australian Patent Application No. 2002228945 (hide)

Owner Merck & Co., Inc. Banyu Pharmaceutical Co., Ltd.

Inventors Hiraga, Shouichi; Satake, Nobuya; Rossen, Kai; Petrillo, Daniel E.; Weissman, Steven A.

Agent Spruson & Ferguson

Pub. Number AU-B-2002228945

PCT Pub. Number WO02/36601

Priority 60/244,675 31.10.00 US

Filing date 26 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 2 February 2006

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

2 February 2006 Application Accepted

  Published as AU-B-2002228945

1 June 2006 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228946

2002228944